EZH2 and familial pancreatic carcinoma: To investigate the relationship between intrinsic gemcitabine resistance and the expression of EZH2 and 5-HT system genes in pancreatic cancer cells, we first compared the levels of resistance and those gene expressions between PDAC cell lines.